One study found that 30% of breast cancer tissues stain positively for BTK and that among 23 HER2-positive human breast cancer tissues 43% were positive for BTK with a statistically significant association of expression of BTK with HER2 expression. The gene discussed is ERBB2; the disease is breast carcinoma.